Alvotech

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the…

Alvotech (NASDAQ: ALVO) og Teva Pharmaceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. (NYSE og TASE: TEVA) tilkynntu í dag um aukið samstarf á sviði þróunar, framleiðslu og markaðssetningar á líftæknilyfjahliðstæðum.…

REYKJAVIK, Iceland, May 31, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in…

<!-- Name:DistributionId Value:1000821636 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

<!-- Name:DistributionId Value:1000808124 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4573 -->…

<!-- Name:DistributionId Value:1000808124 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4573 -->…

<!-- Name:DistributionId Value:1000781638 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC (“GHH”), the…

Alvotech (NASDAQ: ALVO) og Bioventure, dótturfyrirtæki GlobalOne Healthcare Holding LLC, heilbrigðissviðs YAS Holding LLC, tilkynntu í dag að lyfja- og matvælaeftirlit Sádi-Arabíu (SFDA) hafi veitt leyfi til framleiðslu og sölu á AVT02,…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji Pharma Co., Ltd. (“Fuji”, Tokyo Stock Exchange:…